{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:39:11Z","timestamp":1788586751923,"version":"build-2803163510"},"reference-count":57,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100021201","name":"European Academy of Dermatology and Venereology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021201","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic inflammatory skin diseases are frequently associated with addictive behaviours, which may affect disease course, mental health and treatment outcomes. Yet, existing data remain fragmented across addiction types and dermatologic conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To systematically review the prevalence of substance\u2010related and behavioural addictions in adults with selected skin diseases and to evaluate the methodological quality of the available evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search of PubMed and Embase was conducted through April 2025. Eligible studies included observational designs investigating adult populations with alopecia areata, atopic dermatitis, hidradenitis suppurativa, psoriasis, urticaria or vitiligo and reporting outcomes related to alcohol, nicotine substance use or behavioural addictions (e.g. internet or gambling). Methodological quality of the included studies was assessed using the Newcastle\u2013Ottawa Scale (NOS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty\u2010eight studies were included and psoriasis, atopic dermatitis and hidradenitis suppurativa were the most frequently investigated diseases. Alcohol addiction (prevalence up to 50%) and nicotine abuse (up to 40%) were the most common addictions, followed by substance use disorder and behavioural addictions (e.g. internet addiction up to 38%). Addictions were associated with greater disease severity, reduced treatment response and higher comorbidity burden. Two\u2010thirds of studies met &gt;\u200990% of STROBE criteria, but heterogeneity in design, assessment tools and reporting limited comparability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Addictive behaviours are common among patients with chronic skin diseases and may influence clinical outcomes. Systematic screening, particularly for underrecognized behavioural addictions, and age\u2010 and sex\u2010stratified care approaches, should be integrated into dermatological practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jdv.70576","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T09:09:47Z","timestamp":1782551387000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Addiction in chronic inflammatory skin diseases: A systematic review of prevalence, impact and screening practices"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8422-3278","authenticated-orcid":false,"given":"Enya","family":"M\u00fcller","sequence":"first","affiliation":[{"name":"School of Medicine and Health, Department of Dermatology and Allergy Technical University of Munich  Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3176-1120","authenticated-orcid":false,"given":"Stefanie","family":"Ziehfreund","sequence":"additional","affiliation":[{"name":"School of Medicine and Health, Department of Dermatology and Allergy Technical University of Munich  Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Saak","sequence":"additional","affiliation":[{"name":"School of Medicine and Health, Department of Dermatology and Allergy Technical University of Munich  Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Besi","sequence":"additional","affiliation":[{"name":"School of Medicine and Health, Department of Dermatology and Allergy Technical University of Munich  Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0094-2674","authenticated-orcid":false,"given":"Kilian","family":"Eyerich","sequence":"additional","affiliation":[{"name":"Department of Dermatology Medical Center, University of Freiburg  Freiburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9313-6588","authenticated-orcid":false,"given":"Alexander","family":"Zink","sequence":"additional","affiliation":[{"name":"School of Medicine and Health, Department of Dermatology and Allergy Technical University of Munich  Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"issue":"6","key":"e_1_2_15_2_1","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.jaad.2017.01.030","article-title":"Assessment of major comorbidities in adults with atopic dermatitis using the Charlson comorbidity index","volume":"76","author":"Thyssen JP","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"e_1_2_15_3_1","doi-asserted-by":"crossref","first-page":"AB11","DOI":"10.1016\/j.jaad.2021.06.071","article-title":"Increased urine phthalate metabolites are associated with atopic dermatitis in US adults","volume":"85","author":"Roh YS","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"e_1_2_15_4_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149175","article-title":"Comorbidities of psoriasis \u2013 exploring the links by network approach","volume":"11","author":"Sundarrajan S","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"e_1_2_15_5_1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/jamadermatol.2014.2094","article-title":"Effect of psoriasis severity on hypertension control a population\u2010based study in the United Kingdom","volume":"151","author":"Takeshita J","year":"2015","journal-title":"JAMA Dermatol"},{"key":"e_1_2_15_6_1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.880201","article-title":"Epidemiology of psoriasis and comorbid diseases: a narrative review","volume":"13","author":"Bu J","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"e_1_2_15_7_1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: epidemiology","volume":"76","author":"Takeshita J","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_15_8_1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1309549","article-title":"Large\u2010scale epidemiological analysis of common skin diseases to identify shared and unique comorbidities and demographic factors","volume":"14","author":"Li Q","year":"2023","journal-title":"Front Immunol"},{"issue":"2","key":"e_1_2_15_9_1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00403-023-02803-2","article-title":"Comorbid psychiatric disease significantly mediates increased rates of alcohol use disorder among patients with inflammatory and pigmentary skin disorders: a case\u2010control study in the all of us research program","volume":"316","author":"Kamal K","year":"2024","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"e_1_2_15_10_1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/jdv.17875","article-title":"Can crowdsourced data help to optimize atopic dermatitis treatment? Comparing web search data and environmental data in Germany","volume":"36","author":"Mick A","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"e_1_2_15_11_1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/bjd.15497","article-title":"High prevalence of alcohol use disorders in patients with inflammatory skin diseases","volume":"177","author":"Al\u2010Jefri K","year":"2017","journal-title":"Br J Dermatol"},{"issue":"3","key":"e_1_2_15_12_1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.dsi.2013.02.001","article-title":"Stress coping mechanisms in smoking psoriatics","volume":"31","author":"Altunay I","year":"2013","journal-title":"Dermatol Sin"},{"issue":"3","key":"e_1_2_15_13_1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4103\/0019-5154.131382","article-title":"Severity of psoriasis among adult males is associated with smoking, not with alcohol use","volume":"59","author":"Asokan N","year":"2014","journal-title":"Indian J Dermatol"},{"issue":"3","key":"e_1_2_15_14_1","first-page":"889","article-title":"Psoriasis, mental disorders and stress","volume":"33","author":"Biljan D","year":"2009","journal-title":"Coll Antropol"},{"issue":"6","key":"e_1_2_15_15_1","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8060770","article-title":"Use of Secukinumab in a cohort of erythrodermic psoriatic patients: a pilot study","volume":"8","author":"Damiani G","year":"2019","journal-title":"J Clin Med"},{"issue":"5","key":"e_1_2_15_16_1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/all.13085","article-title":"Prevalence of comorbidity and associated risk factors in adults with atopic dermatitis","volume":"72","author":"Egeberg A","year":"2017","journal-title":"Allergy"},{"issue":"3","key":"e_1_2_15_17_1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jsxm.2016.12.233","article-title":"Erectile dysfunction in male adults with atopic dermatitis and psoriasis","volume":"14","author":"Egeberg A","year":"2017","journal-title":"J Sex Med"},{"issue":"5","key":"e_1_2_15_18_1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.5664\/jcsm.5790","article-title":"Psoriasis and sleep apnea: a Danish Nationwide cohort study","volume":"12","author":"Egeberg A","year":"2016","journal-title":"J Clin Sleep Med"},{"issue":"3","key":"e_1_2_15_19_1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/YIC.0000000000000511","article-title":"Mental health in patients affected by atopic dermatitis: which effects of treatment with dupilumab?","volume":"39","author":"Ferrucci SM","year":"2024","journal-title":"Int Clin Psychopharmacol"},{"issue":"2","key":"e_1_2_15_20_1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s10880-018-9580-9","article-title":"Psychological distress, alexithymia and alcohol misuse in patients with psoriasis: a cross\u2010sectional study","volume":"26","author":"Founta O","year":"2019","journal-title":"J Clin Psychol Med Settings"},{"issue":"3","key":"e_1_2_15_21_1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jaad.2018.02.053","article-title":"Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: a population\u2010based analysis in the United States","volume":"79","author":"Garg A","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"e_1_2_15_22_1","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/bjd.20577","article-title":"Alcohol misuse is associated with poor response to systemic therapies for psoriasis: findings from a prospective multicentre cohort study","volume":"185","author":"Iskandar IYK","year":"2021","journal-title":"Br J Dermatol"},{"issue":"4","key":"e_1_2_15_23_1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s13555-018-0264-z","article-title":"The comorbidity burden of hidradenitis Suppurativa in the United States: a claims data analysis","volume":"8","author":"Kimball AB","year":"2018","journal-title":"Dermatol Ther"},{"issue":"1","key":"e_1_2_15_24_1","first-page":"138","article-title":"Alcohol consumption and psychological distress in patients with psoriasis","volume":"158","author":"Kirby B","year":"2008","journal-title":"Br J Dermatol"},{"issue":"6","key":"e_1_2_15_25_1","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/ijd.17186","article-title":"Risk of cardiovascular disorders in hidradenitis suppurativa patients: a large\u2010scale, propensity\u2010matched global retrospective cohort study","volume":"63","author":"Krajewski PK","year":"2024","journal-title":"Int J Dermatol"},{"issue":"6","key":"e_1_2_15_26_1","first-page":"298","article-title":"Diseases associated with psoriasis in a general population of 159,200 middle\u2010aged, urban, native swedes","volume":"172","author":"Lindeg\u00e5rd B","year":"1986","journal-title":"Dermatologica"},{"issue":"6","key":"e_1_2_15_27_1","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1365-2133.2011.10345.x","article-title":"Alcohol misuse in patients with psoriasis: identification and relationship to disease severity and psychological distress","volume":"164","author":"McAleer MA","year":"2011","journal-title":"Br J Dermatol"},{"key":"e_1_2_15_28_1","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.941255","article-title":"Effects of alcohol intake, smoking, and diet evaluated using the alcohol use disorder identification test questionnaire on the severity of plaque psoriasis in 44 patients using the body surface area and psoriasis area and severity index scales, and quality of life using the dermatology life quality index questionnaire","volume":"29","author":"Michalski P","year":"2023","journal-title":"Med Sci Monit"},{"issue":"4","key":"e_1_2_15_29_1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00403-024-02841-4","article-title":"Cracking the code: unveiling the nexus between atopic dermatitis and addictive behavior: a cross\u2010sectional exploration of risk factors","volume":"316","author":"Mick A","year":"2024","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"e_1_2_15_30_1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/ana.26672","article-title":"Shared genetic risk factors for multiple sclerosis\/psoriasis suggest involvement of Interleukin\u201017 and Janus kinase\u2010signal transducers and activators of transcription signaling","volume":"94","author":"Patrick MT","year":"2023","journal-title":"Ann Neurol"},{"issue":"1","key":"e_1_2_15_31_1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/jdv.17708","article-title":"Addictions in patients with atopic dermatitis: a cross\u2010sectional pilot study in Germany","volume":"36","author":"Pilz AC","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"e_1_2_15_32_1","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s13555-020-00401-y","article-title":"Hidradenitis Suppurativa and concurrent psoriasis: comparison of epidemiology, comorbidity profiles, and risk factors","volume":"10","author":"Pinter A","year":"2020","journal-title":"Dermatol Ther"},{"key":"e_1_2_15_33_1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ajp.2017.04.018","article-title":"Pattern and prevalence of psychiatric disorders among patients attending dermatology OPD","volume":"29","author":"Raikhy S","year":"2017","journal-title":"Asian J Psychiatr"},{"issue":"6","key":"e_1_2_15_34_1","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/1346-8138.15740","article-title":"People\u2010centered care for psoriasis and urticaria: are we overlooking internet addiction while only considering patients and physician settings?","volume":"48","author":"Schielein MC","year":"2021","journal-title":"J Dermatol"},{"issue":"6","key":"e_1_2_15_35_1","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1684\/ejd.2021.4146","article-title":"Psoriasis and addiction: assessing mental health based on a cross\u2010sectional study in Germany","volume":"31","author":"Schielein MC","year":"2021","journal-title":"Eur J Dermatol"},{"issue":"6","key":"e_1_2_15_36_1","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9061818","article-title":"Always online? Internet addiction and social impairment in psoriasis across Germany","volume":"9","author":"Schielein MC","year":"2020","journal-title":"J Clin Med"},{"issue":"9","key":"e_1_2_15_37_1","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1007\/s12325-021-01845-0","article-title":"Alopecia Areata treatment patterns, healthcare resource utilization, and comorbidities in the US population using insurance claims","volume":"38","author":"Senna M","year":"2021","journal-title":"Adv Ther"},{"issue":"6","key":"e_1_2_15_38_1","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jaad.2014.09.012","article-title":"Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart\u2010verified case\u2010control analysis","volume":"71","author":"Shlyankevich J","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"e_1_2_15_39_1","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/ijd.16228","article-title":"Comorbid diseases of hidradenitis suppurativa: a 15\u2010year population\u2010based study in Olmsted County, Minnesota, USA","volume":"61","author":"Sokumbi O","year":"2022","journal-title":"Int J Dermatol"},{"issue":"6","key":"e_1_2_15_40_1","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/1346-8138.15721","article-title":"Psychological burden of psoriatic patients in a German university hospital dermatology department","volume":"48","author":"Sondermann W","year":"2021","journal-title":"J Dermatol"},{"issue":"3","key":"e_1_2_15_41_1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s40257-019-00489-9","article-title":"Risk for suicidal behavior among psoriasis patients: a Nationwide cohort study","volume":"21","author":"Wang SH","year":"2020","journal-title":"Am J Clin Dermatol"},{"issue":"8","key":"e_1_2_15_42_1","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/jdv.14204","article-title":"Addiction: an underestimated problem in psoriasis health care","volume":"31","author":"Zink A","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"e_1_2_15_43_1","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v105.41350","article-title":"Patterns of addiction in chronic skin diseases: a comparative analysis of addictions and influencing factors in atopic dermatitis and psoriasis","volume":"105","author":"Mazilu R","year":"2025","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"e_1_2_15_44_1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.12788\/cutis.1130","article-title":"Eating disorder risk factors and the impact of obesity in patients with psoriasis","volume":"114","author":"Temel B","year":"2024","journal-title":"Cutis"},{"issue":"1","key":"e_1_2_15_45_1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12872-021-01972-0","article-title":"Psoriasis as risk factor for non\u2010ischemic dilated cardiomyopathy: a population\u2010based cross\u2010sectional study","volume":"21","author":"Alshami A","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"e_1_2_15_46_1","unstructured":"ZiehfreundS SaakM SchaalA MaziluR Mah\u00e9E HajjC et\u00a0al.Addiction and chronic skin diseases: a pan\u2010European study on prevalence associations and patient impact.J Eur Acad Dermatol Venereol: 702452025."},{"issue":"3","key":"e_1_2_15_47_1","first-page":"105","article-title":"Alcohol consumption and smoking habits in patients with psoriasis","volume":"8","author":"Gruber F","year":"1999","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"issue":"7","key":"e_1_2_15_48_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta\u2010analyses: the PRISMA statement","volume":"6","author":"Moher D","year":"2009","journal-title":"PLoS Med"},{"key":"e_1_2_15_49_1","unstructured":"PROSPERO\u2014International prospective register of systematic reviews. NIHR. Accessed April 24 2025. Available from:https:\/\/www.crd.york.ac.uk\/prospero\/"},{"issue":"4","key":"e_1_2_15_50_1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"Elm E","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"e_1_2_15_51_1","unstructured":"Institute OHR.The Newcastle\u2010Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta\u2010analysis. Accessed 20 12 2025. Available from:https:\/\/ohri.ca\/en\/who\u2010we\u2010are\/core\u2010facilities\u2010and\u2010platforms\/ottawa\u2010methods\u2010centre\/newcastle\u2010ottawa\u2010scale"},{"issue":"4","key":"e_1_2_15_52_1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMra1511480","article-title":"Neurobiologic advances from the brain disease model of addiction","volume":"374","author":"Volkow ND","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"e_1_2_15_53_1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00787-023-02173-0","article-title":"Prevalence of substance use disorders and associations with mindfulness, impulsive personality traits and psychopathological symptoms in a representative sample of adolescents in Germany","volume":"33","author":"Arnaud N","year":"2024","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"4","key":"e_1_2_15_54_1","first-page":"271","article-title":"Epidemiology of substance use and substance use disorders in Germany","volume":"53","author":"K\u00fcfner H","year":"2010","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"9","key":"e_1_2_15_55_1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle\u2010Ottawa scale for the assessment of the quality of nonrandomized studies in meta\u2010analyses","volume":"25","author":"Stang A","year":"2010","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"e_1_2_15_56_1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.5114\/ada.2023.129308","article-title":"A crossroads between dietary habits, alcohol consumption, and smoking in the clinical course of psoriasis: a narrative review","volume":"40","author":"Michalski P","year":"2023","journal-title":"Postepy Dermatol Alergol"},{"issue":"6","key":"e_1_2_15_57_1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/YCO.0000000000000278","article-title":"Epidemiology of eating disorders in Europe: prevalence, incidence, comorbidity, course, consequences, and risk factors","volume":"29","author":"Keski\u2010Rahkonen A","year":"2016","journal-title":"Curr Opin Psychiatry"},{"issue":"8","key":"e_1_2_15_58_1","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitry analysis","volume":"3","author":"Koob GF","year":"2016","journal-title":"Lancet Psychiatry"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.70576","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jdv.70576","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.70576","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T09:09:58Z","timestamp":1782551398000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.70576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":57,"alternative-id":["10.1111\/jdv.70576"],"URL":"https:\/\/doi.org\/10.1111\/jdv.70576","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"2025-09-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"jdv.70576"}}